Teijin plans to increase the annual capacity of Biofront to 5,000 tons by fiscal 2011, and scale it further in the next decade.

Biofront, first developed in 2006 and launched in 2007, is described as the world’s first mass-produced stereocomplex PLA, made with plant-based Poly-L-lacticacid polymer (conventional polylacticacid polymer) and their enantiomer poly-D-lacticacid polymer. It is expected to be used in a range of sustainable clothing, eco-textiles and accessories such as buttons. The Biofront plant in Matsuyama was originally Toyota Motor Corporation’s polylactic acid demonstration plant. Following the acquisition of the plant by Teijin in June 2008, it was migrated to Matsuyama and converted into a demonstration plant for Biofront with additional proprietary processes required for producing the heat-resistant bioplastic.
  More News  Post Your Comment
{{comment.Name}} made a post.




There are no comments to display. Be the first one to comment!


Name Required.


Email Id Required.

Email Id Not Valid.


Mobile Required.

Email ID and Mobile Number are kept private and will not be shown publicly.

Message Required.

Click to Change image  Refresh Captcha